Alle News

Abstract digital background

AI, Awards & Grants, Computational Health, ICB,

Helmholtz Munich to Advance AI Benchmarking With Three Newly Funded Projects

Helmholtz Munich has secured funding in the Helmholtz Association’s first-ever “UNLOCK” call for AI benchmarking. With three projects approved, the center plays a key role in developing high-quality, multimodal benchmarking datasets that will improve…

Histology of human epididymis tissue under the microscope.

AI, New Research Findings, Computational Health, ICB,

New Foundation Model Reveals How Cells Are Organized in Tissues

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first large-scale foundation model that integrates single-cell analysis with spatial transcriptomics. Trained on more than 110 million cells,…

Prologue with Eric Topol

AI, Computational Health, ICB,

Prof. Eric Topol Visits Helmholtz Munich for Roundtable on “Virtual Human”

Helmholtz Munich had the pleasure to welcome Prof. Eric Topol, internationally recognized cardiologist, geneticist, and digital medicine expert, for a roundtable on the future of AI in healthcare. The event, serving as a prologue to the Bavarian…

Icon, Computational Health, Featured Publication

Featured Publication, Computational Health, ICB,

Investigating a Fundamental Biological Process in Vaccinated Individuals

When immune system killer cells detect signs of infection, some of them rapidly multiply, forming a large defensive force to fight the pathogen. However, this response does not occur in every killer cell. What determines whether a cell will…

Icon, Computational Health, Featured Publication

AI, Featured Publication, Computational Health, ICB,

Integrated Single-Cell Atlas of Human Atherosclerotic Plaques

Researchers from Helmholtz Munich, Roche Diagnostics, and the Technical University of Munich have developed the most comprehensive single-cell atlas to date of human atherosclerotic plaques. These plaques, which form in the arteries and can lead to…

Human lung model

AI, Environmental Health, PRM, Computational Health, ICB,

New Collaboration to Advance Drug Discovery for Pulmonary Fibrosis

Helmholtz Munich and Boehringer Ingelheim have started a research collaboration to identify new avenues for the treatment of idiopathic pulmonary fibrosis that could improve outcomes in people living with this severe and progressive lung disease.…